Illumina, Inc (NASDAQ:ILMN) Launches Multiomics Push, Likely To Reaccelerate Revenue Growth
![]() |
Illumina entered a fresh phase of product and market activity this autumn, with new technology releases and regulatory developments that support a near-term constructive bias for revenue recovery. The company’s steady profitability and robust cash position anchor the valuation as operational momentum builds. |








